Hoitt Jason 4
4 · Dova Pharmaceuticals Inc. · Filed Jul 16, 2019
Insider Transaction Report
Form 4
Hoitt Jason
Chief Commercial Officer
Transactions
- Sale
Common Stock
2019-07-15$16.44/sh−900$14,796→ 12,357 total - Sale
Common Stock
2019-07-15$15.10/sh−6,680$100,868→ 13,257 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.99 inclusive.